<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04303013</url>
  </required_header>
  <id_info>
    <org_study_id>18-004546</org_study_id>
    <nct_id>NCT04303013</nct_id>
  </id_info>
  <brief_title>Guided Meditation During Radiotherapy.</brief_title>
  <official_title>A Randomized Controlled Trial of Guided Mindfulness Intervention During Radiotherapy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to gather information on the effects of Mindfulness-Based
      Intervention (MBI) on quality of life during and after radiation treatment.

      This study involves randomization. There is a 50 percent chance (like a flip of the coin)
      that you will be randomized to attend meditation sessions during treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of Meditation Sessions</measure>
    <time_frame>Before radiation treatment.</time_frame>
    <description>including emotional, physical, functional, and social domains assessed via the FACT-G during and after radiotherapy for the treatment of cancer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness of Meditation Sessions</measure>
    <time_frame>During radiation treatment</time_frame>
    <description>Comparison of change in total LASA-6 and single question relaxation surveys.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness of Meditation Sessions</measure>
    <time_frame>3 months and 12 months post radiation treatment.</time_frame>
    <description>Comparison of change in FACT-G, Promis 10 and LASA-6 surveys.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Quality of Life</condition>
  <condition>Relaxation During Radiation Therapy</condition>
  <condition>Cancer</condition>
  <condition>Radiation Toxicity</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Meditation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Meditation</intervention_name>
    <description>Patients will attend weekly in person guided meditation sessions during the course of their radiation treatment. Patient will complete quality of life surveys before, during and after treatment.</description>
    <arm_group_label>Meditation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>Patient not assigned to meditation will undergo radiation with usual care and complete quality of life surveys before, during and after treatment.</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18 years

          -  Prescribed a course of at least 15 daily fractions of RT for curative intent of any
             malignancy

          -  Willing to attend MBI sessions weekly during RT

          -  Able to transport themselves to scheduled MBI sessions in the DAHLC

          -  Able to complete questionnaire(s) by themselves

          -  Native English speaker (MBI sessions, videos, and QOL questionnaires are only
             available in English)

          -  ECOG Performance Status 0-2

        Exclusion Criteria:

          -  Prescribed a course of RT with fewer than 15 consecutive, daily fractions

          -  Unable or unwilling to attend required MBI sessions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jennifer Haen</last_name>
    <phone>507-293-2668</phone>
    <email>haen.jennifer@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica Schneider</last_name>
    <phone>507-293-1230</phone>
    <email>schneider.jessica1@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenny Haen</last_name>
      <phone>507-293-2668</phone>
      <email>haen.jennifer@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2020</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Kimberly S. Corbin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

